Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) announces that, effective today, it has been named to the NASDAQ Global Select Market tier, the premier listing tier for NASDAQ companies. The NASDAQ Global Select Market tier was created in July 2006 for companies that meet the highest listing standards in the world, based on financial and liquidity requirements.
"We are delighted by the recognition of our financial strength and by the fact that Infinity stock will now be trading on the top tier of the NASDAQ Stock Market," stated Adelene Q. Perkins, president and chief executive officer of Infinity. "Our strong financial profile enables us to advance a broad portfolio of product candidates that have the potential to meaningfully impact patients' lives, and thereby create long-term value for shareholders."
Following elevation to the NASDAQ Global Select Market, the company's ticker symbol remains INFI. Infinity shares previously traded on the NASDAQ Global Market. Currently, NASDAQ-listed companies are classified under three listing tiers – NASDAQ Global Select Market, NASDAQ Global Market, and NASDAQ Capital Market.